[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6243 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 6243

 To direct the Secretary of Labor to issue an occupational safety and 
    health standard that requires employers to keep opioid overdose 
   reversal drugs onsite and develop and implement training plans to 
  respond to drug overdose emergencies and to amend the Omnibus Crime 
 Control and Safe Streets Act of 1968 to expand the grants authorized 
          under the Comprehensive Opioid Abuse Grant Program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            November 6, 2023

Mr. Gallego (for himself and Mr. Nunn of Iowa) introduced the following 
    bill; which was referred to the Committee on Education and the 
  Workforce, and in addition to the Committee on the Judiciary, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Labor to issue an occupational safety and 
    health standard that requires employers to keep opioid overdose 
   reversal drugs onsite and develop and implement training plans to 
  respond to drug overdose emergencies and to amend the Omnibus Crime 
 Control and Safe Streets Act of 1968 to expand the grants authorized 
          under the Comprehensive Opioid Abuse Grant Program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Overdose Reversal Medication Act'' 
or the ``ORM Act''.

SEC. 2. OPIOID OVERDOSE REVERSAL DRUG STANDARD.

    (a) Interim Final Standard.--
            (1) In general.--Not later than 1 year after the date of 
        enactment of this Act, the Secretary of Labor shall issue an 
        interim final standard on workplace availability of an opioid 
        overdose reversal drug or device--
                    (A) to require all employers to possess an opioid 
                overdose reversal drug or device on site, where the 
                required number of doses of such drug or device 
                required is determined on the basis of the number of 
                employees of the employer on site, type of occupation, 
                and an assessment of potential use;
                    (B) that establishes guidelines for training on--
                            (i) identifying signs and symptoms 
                        indicating that usage of an opioid overdose 
                        drug or device is necessary; and
                            (ii) how to administer such opioid overdose 
                        reversal drug or device; and
                    (C) that provides for a period as determined 
                appropriate by the Secretary, not to exceed 1 year, 
                during which the Secretary shall prioritize technical 
                assistance and advice consistent with section 21(d) of 
                the Occupational Safety and Health Act of 1970 (29 
                U.S.C. 670(d)) to employers subject to the standard 
                with respect to compliance with the standard.
            (2) Effective date of interim standard.--The interim final 
        standard shall--
                    (A) take effect on a date that is not later than 30 
                days after issuance;
                    (B) shall have the same legal effect as an 
                occupational safety and health standard as defined by 
                section 3 of the Occupational Safety and Health Act of 
                1970 (29 U.S.C. 652); and
                    (C) be in effect until the final standard described 
                in subsection (b) becomes effective and enforceable.
            (3) Failure to promulgate.--If an interim final standard 
        described in paragraph (1) is not issued by the date that is 1 
        year after the date of enactment of this Act, the provisions of 
        this Act shall be in effect and enforced in the same manner and 
        to the same extent as any standard promulgated under section 
        6(b) of the Occupational Safety and Health Act (29 U.S.C. 
        655(b)) until such provisions are superseded in whole by an 
        interim final standard issued by the Secretary that meets the 
        requirements of paragraph (1).
    (b) Final Standard.--Not later than 2 years after the date of 
enactment of this Act, the Secretary of Labor shall, pursuant to 
section 6 of the Occupational Safety and Health Act (29 U.S.C. 655), 
promulgate a final standard on workplace availability of opioid 
overdose reversal drugs or devices--
            (1) for the purposes described in subsection (a)(1)(A);
            (2) that shall include, at a minimum, requirements 
        contained in the interim final standard promulgated under 
        subsection (a); and
            (3) be effective and enforceable in the same manner and to 
        the same extent as any standard promulgated under section 6(b) 
        of the Occupational Safety and Health Act of 1970 (29 U.S.C. 
        655(b)).
    (c) Definitions.--In this section:
            (1) Employee; employer.--The terms ``employee'' and 
        ``employer'' have the meaning given such terms in section 3 of 
        the Occupational Safety and Health Act of 1970 (29 U.S.C. 652).
            (2) Opioid overdose reversal drug or device.--The term 
        ``opioid overdose reversal drug or device'' means an opioid 
        overdose reversal drug or device approved, licensed, cleared, 
        or otherwise authorized for marketing by the Food and Drug 
        Administration.
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Labor.

SEC. 3. EXPANSION OF THE COMPREHENSIVE OPIOID ABUSE GRANT PROGRAM.

    Section 3021 of title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10701(a)) is amended--
            (1) in subsection (a), by adding at the end the following:
            ``(11) Developing, implementing, or expanding a program 
        (which may include demonstration projects) that--
                    ``(A) provides training on carrying and 
                administering an opioid overdose reversal drug or 
                device approved, licensed, cleared, or otherwise 
                authorized for marketing by the Food and Drug 
                Administration for local businesses, individuals, or 
                other community entities that are likely to encounter 
                individuals with substance use disorders, but are not 
                eligible for other Federal grant programs or to receive 
                training or resources under such a grant program 
                related to substance use prevention and treatment; or
                    ``(B) provides resources for employers, 
                individuals, or community entities described in 
                subparagraph (A) who have received training described 
                in subparagraph (A) to acquire, carry, and administer 
                such a drug or device.''; and
            (2) by adding at the end the following:
    ``(g) Preferential Consideration.--In awarding grants under this 
part, the Attorney General may give preferential consideration to an 
application from an applicant in a State that has in effect a law that 
exempts from criminal and civil liability individuals who carry or 
administer in good faith an opioid overdose reversal drug or device 
approved, licensed, cleared, or otherwise authorized for marketing by 
the Food and Drug Administration, if such an individual has been 
trained to carry or administer such drug or device.''.
                                 <all>